fda ban on tirzepatide Lilly seeks to intervene in compounded lawsuit Speak up and share your

10.1038/s41387-022-00213-3 Nutr Diabetes

The EXSCEL (NCT01144338), HARMONY (NCT02465515), REWIND ( NCT01394952), and AMPLITUDE-O (NCT03496298) trials all demonstrated cardioprotection or near misses for exenatide, albiglutide, dulaglutide and efpeglenatide, respectively

DNA based and stimuli-responsive smart nanocarrier for diagnosis and treatment of cancer: applications and challenges

Any changes in facial appearance (Ozempic face) are a result of rapid weight loss, not a gender-specific side effect

Oral semaglutide titrated to 14 mg daily reduced 3-point MACE by 14% in SOUL (HR 0.86, 95% CI 0.770.96), with the principal driver a 26% reduction in nonfatal MI

Scholz D, Pltl D, Genewsky A, Weng M, Waldmann T, Schildknecht S, et al